source
- Eli Lilly commits $100M upfront in new five-target partnership with China's InnoCareEli Lilly has agreed to pay $100 million upfront and in the near term to Chinese biotech InnoCare Pharma as part of a five‑target drug discovery partnership. The agreement also provides for up to $…
- Adagio Medical begins strategic review and cuts over half its workforce amid Nasdaq delisting riskAdagio Medical, a maker of cryoablation devices, announced it is launching a strategic review of its operations. As part of the review, the company will lay off more than half of its full‑time sta…